COMBINED USE OF PROPAFEON AND LIDOFLAZINE IN CHRONIC ATRIAL-FIBRILLATION AND FLUTTER

被引:9
作者
BECK, OA
HOCHREIN, H
机构
关键词
D O I
10.1055/s-2008-1070848
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1243 / 1246
页数:4
相关论文
共 19 条
[1]  
Beck O A, 1975, MMW Munch Med Wochenschr, V117, P1369
[2]  
BECK OA, 1975, MED KLIN, V70, P1713
[3]   INDICATIONS AND RISKS OF ANTI-ARRHYTHMIA TREATMENT WITH PROPAFENONE [J].
BECK, OA ;
HOCHREIN, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1978, 103 (32) :1261-1265
[4]   PROPAFENON AND LIDOFLAZINE IN CHRONIC ATRIAL-FIBRILLATION AND FLUTTER [J].
BECK, OA ;
LEHMANN, HU ;
HOCHREIN, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1978, 103 (26) :1068-1072
[5]  
BECK OA, 1975, Z KARDIOL, V64, P179
[6]  
BECK OA, 1975, MED KLIN, V70, P95
[7]  
BECK OA, 1975, LIDOFLAZIN, P105
[8]  
BERGMANN M, 1977, FORTSCHRITTE PHARMAK, P29
[9]  
CARMELEIT E, 1974, ARZNEIMITTEL-FORSCH, V26, P16
[10]  
HAPKE HJ, 1976, ARZNEIMITTEL-FORSCH, V26, P1849